Cargando…

Aliskiren and valsartan combination therapy for the management of hypertension

Combination therapy is necessary for most patients with hypertension, and agents that inhibit the renin-angiotensin-aldosterone system (RAAS) are mainstays in hypertension management, especially for patients at high cardiovascular and renal risk. Single blockade of the RAAS with an angiotensin-conve...

Descripción completa

Detalles Bibliográficos
Autor principal: Epstein, Benjamin J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941784/
https://www.ncbi.nlm.nih.gov/pubmed/20859542